{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,11,2]],"date-time":"2026-11-02T00:53:08Z","timestamp":1793580788217,"version":"4.5.0"},"reference-count":106,"publisher":"Springer Science and Business Media LLC","issue":"1","license":[{"start":{"date-parts":[[2025,11,29]],"date-time":"2025-11-29T00:00:00Z","timestamp":1764374400000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by-nc-nd\/4.0"},{"start":{"date-parts":[[2026,1,5]],"date-time":"2026-01-05T00:00:00Z","timestamp":1767571200000},"content-version":"vor","delay-in-days":37,"URL":"https:\/\/creativecommons.org\/licenses\/by-nc-nd\/4.0"}],"funder":[{"DOI":"10.13039\/501100001809","name":"National Natural Science Foundation of China","doi-asserted-by":"crossref","award":["82372109"],"award-info":[{"award-number":["82372109"]}],"id":[{"id":"10.13039\/501100001809","id-type":"DOI","asserted-by":"crossref"}]}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["J Nanobiotechnol"],"DOI":"10.1186\/s12951-025-03883-0","type":"journal-article","created":{"date-parts":[[2025,11,29]],"date-time":"2025-11-29T16:43:42Z","timestamp":1764434622000},"update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":6,"title":["The potential of nanotechnology for photothermal therapy-based synergistic immunotherapy: a review"],"prefix":"10.1186","volume":"24","author":[{"given":"Xiao-Kai","family":"Chi","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Xiao","family":"Zhang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jin","family":"Su","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yong-Zhong","family":"Du","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Xiao-Ling","family":"Xu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2025,11,29]]},"reference":[{"issue":"1","key":"3883_CR1","doi-asserted-by":"publisher","first-page":"17","DOI":"10.3322\/caac.21763","volume":"73","author":"RL Siegel","year":"2023","unstructured":"Siegel RL, Miller KD, Wagle NS, Jemal A. Cancer statistics, 2023. CA Cancer J Clin. 2023;73(1):17\u201348. https:\/\/doi.org\/10.3322\/caac.21763.","journal-title":"CA Cancer J Clin"},{"issue":"3","key":"3883_CR2","doi-asserted-by":"publisher","first-page":"209","DOI":"10.3322\/caac.21660","volume":"71","author":"H Sung","year":"2021","unstructured":"Sung H, Ferlay J, Siegel RL, et al. Global Cancer Statistics 2020: GLOBOCAN Estimates of Incidence and Mortality Worldwide for 36 Cancers in 185 Countries. CA Cancer J Clin. 2021;71(3):209\u201349. https:\/\/doi.org\/10.3322\/caac.21660.","journal-title":"CA Cancer J Clin"},{"issue":"7","key":"3883_CR3","doi-asserted-by":"publisher","first-page":"585","DOI":"10.1056\/NEJMoa2207586","volume":"388","author":"IH Kunkler","year":"2023","unstructured":"Kunkler IH, Williams LJ, Jack WJL, Cameron DA, Dixon JM. Breast-conserving surgery with or without irradiation in early breast cancer. N Engl J Med. 2023;388(7):585\u201394. https:\/\/doi.org\/10.1056\/NEJMoa2207586.","journal-title":"N Engl J Med"},{"issue":"12","key":"3883_CR4","doi-asserted-by":"publisher","DOI":"10.1002\/advs.202104728.","volume":"9","author":"RQ Yang","year":"2022","unstructured":"Yang RQ, Wang PY, Lou KL, et al. Biodegradable nanoprobe for NIR-II fluorescence image-guided surgery and enhanced breast cancer radiotherapy efficacy. Adv Sci. 2022;9(12):e2104728. https:\/\/doi.org\/10.1002\/advs.202104728.","journal-title":"Adv Sci"},{"issue":"6","key":"3883_CR5","doi-asserted-by":"publisher","first-page":"1072","DOI":"10.1158\/1078-0432.CCR-21-2600.","volume":"28","author":"S Arora","year":"2022","unstructured":"Arora S, Narayan P, Osgood CL, et al. U.S. FDA drug approvals for breast cancer: a decade in review. Clin Cancer Res. 2022;28(6):1072\u201386. https:\/\/doi.org\/10.1158\/1078-0432.CCR-21-2600.","journal-title":"Clin Cancer Res"},{"issue":"5","key":"3883_CR6","doi-asserted-by":"publisher","first-page":"409","DOI":"10.3322\/caac.21731.","volume":"72","author":"KD Miller","year":"2022","unstructured":"Miller KD, Nogueira L, Devasia T, et al. Cancer treatment and survivorship statistics, 2022. CA Cancer J Clin. 2022;72(5):409\u201336. https:\/\/doi.org\/10.3322\/caac.21731.","journal-title":"CA Cancer J Clin"},{"key":"3883_CR7","doi-asserted-by":"publisher","first-page":"103953","DOI":"10.1016\/j.critrevonc.2023.103953","volume":"184","author":"X Ma","year":"2023","unstructured":"Ma X, Fang J, Zhang L, et al. Efficacy and safety of adjuvant chemotherapy for locally advanced cervical cancer: A systematic review and meta-analysis. Crit Rev Oncol Hematol. 2023;184:103953. https:\/\/doi.org\/10.1016\/j.critrevonc.2023.103953.","journal-title":"Crit Rev Oncol Hematol"},{"key":"3883_CR8","doi-asserted-by":"publisher","first-page":"1051998","DOI":"10.3389\/fimmu.2022.1051998","volume":"13","author":"W Zhang","year":"2022","unstructured":"Zhang W, Li S, Li C, Li T, Huang Y. Remodeling tumor microenvironment with natural products to overcome drug resistance. Front Immunol. 2022;13:1051998. https:\/\/doi.org\/10.3389\/fimmu.2022.1051998. Published 2022 Nov 10.","journal-title":"Front Immunol"},{"issue":"14","key":"3883_CR9","doi-asserted-by":"publisher","first-page":"2503","DOI":"10.1158\/0008-5472.CAN-21-3844","volume":"82","author":"PK Dhanyamraju","year":"2022","unstructured":"Dhanyamraju PK, Schell TD, Amin S, Robertson GP. Drug-tolerant persister cells in cancer therapy resistance. Cancer Res. 2022;82(14):2503\u201314. https:\/\/doi.org\/10.1158\/0008-5472.CAN-21-3844.","journal-title":"Cancer Res"},{"issue":"7","key":"3883_CR10","doi-asserted-by":"publisher","first-page":"3019","DOI":"10.7150\/ijbs.72534","volume":"18","author":"A Zhang","year":"2022","unstructured":"Zhang A, Miao K, Sun H, Deng CX. Tumor heterogeneity reshapes the tumor microenvironment to influence drug resistance. Int J Biol Sci. 2022;18(7):3019\u201333. https:\/\/doi.org\/10.7150\/ijbs.72534.","journal-title":"Int J Biol Sci"},{"key":"3883_CR11","doi-asserted-by":"publisher","first-page":"7987","DOI":"10.2147\/IJN.S526497","volume":"20","author":"H Sun","year":"2025","unstructured":"Sun H, Li Y, Xue M, Feng D. Tumor microenvironment-responsive nanoparticles: promising cancer PTT carriers. Int J Nanomed. 2025;20:7987\u20138001. https:\/\/doi.org\/10.2147\/IJN.S526497.","journal-title":"Int J Nanomed"},{"key":"3883_CR12","doi-asserted-by":"publisher","DOI":"10.1016\/j.pdpdt.2024.104387","volume":"50","author":"CF Cuadrado","year":"2024","unstructured":"Cuadrado CF, Lagos KJ, Stringasci MD, Bagnato VS, Romero MP. Clinical and pre-clinical advances in the PDT\/PTT strategy for diagnosis and treatment of cancer. Photodiagnosis Photodyn Ther. 2024;50:104387. https:\/\/doi.org\/10.1016\/j.pdpdt.2024.104387.","journal-title":"Photodiagnosis Photodyn Ther"},{"key":"3883_CR13","doi-asserted-by":"publisher","DOI":"10.1016\/j.pdpdt.2023.103312","volume":"42","author":"MA Dheyab","year":"2023","unstructured":"Dheyab MA, Aziz AA, Khaniabadi PM, et al. Gold nanoparticles-based photothermal therapy for breast cancer. Photodiagnosis Photodyn Ther. 2023;42:103312. https:\/\/doi.org\/10.1016\/j.pdpdt.2023.103312.","journal-title":"Photodiagnosis Photodyn Ther"},{"issue":"1","key":"3883_CR14","doi-asserted-by":"publisher","DOI":"10.1038\/s41392-025-02140-y","volume":"10","author":"Y Cai","year":"2025","unstructured":"Cai Y, Chai T, Nguyen W, et al. Phototherapy in cancer treatment: strategies and challenges. Signal Transduct Target Ther. 2025;10(1):115. https:\/\/doi.org\/10.1038\/s41392-025-02140-y.","journal-title":"Signal Transduct Target Ther"},{"issue":"11","key":"3883_CR15","doi-asserted-by":"publisher","first-page":"4504","DOI":"10.1021\/acsabm.3c00518","volume":"6","author":"Z Yang","year":"2023","unstructured":"Yang Z, Yang X, Guo Y, Kawasaki H. A review on gold nanoclusters for cancer phototherapy. ACS Appl Bio Mater. 2023;6(11):4504\u201317. https:\/\/doi.org\/10.1021\/acsabm.3c00518.","journal-title":"ACS Appl Bio Mater"},{"key":"3883_CR16","doi-asserted-by":"publisher","first-page":"3021","DOI":"10.2147\/IJN.S4141173","volume":"18","author":"J He","year":"2023","unstructured":"He J, Song R, Xiao F, Wang M, Wen L. CuP\/1-MT nanocomposites potentiated photothermal-immunotherapy. Int J Nanomed. 2023;18:3021\u201333. https:\/\/doi.org\/10.2147\/IJN.S4141173.","journal-title":"Int J Nanomed"},{"issue":"1","key":"3883_CR17","doi-asserted-by":"publisher","DOI":"10.1038\/s41392-024-01859-4","volume":"9","author":"Y Yang","year":"2024","unstructured":"Yang Y, Liu Q, Wang M, et al. Genetically programmable cell membrane-camouflaged nanoparticles for targeted combination therapy of colorectal cancer. Signal Transduct Target Ther. 2024;9(1):158. https:\/\/doi.org\/10.1038\/s41392-024-01859-4.","journal-title":"Signal Transduct Target Ther"},{"issue":"52","key":"3883_CR18","doi-asserted-by":"publisher","DOI":"10.1002\/adma.202305668","volume":"35","author":"M Cui","year":"2023","unstructured":"Cui M, Tang D, Wang B, Zhang H, Liang G, Xiao H. Bioorthogonal guided activation of cGAS-STING by AIE photosensitizer nanoparticles for targeted tumor therapy and imaging. Adv Mater. 2023;35(52):e2305668. https:\/\/doi.org\/10.1002\/adma.202305668.","journal-title":"Adv Mater"},{"issue":"1","key":"3883_CR19","doi-asserted-by":"publisher","DOI":"10.1038\/s41392-025-02140-y","volume":"10","author":"Y Cai","year":"2025","unstructured":"Cai Y, Chai T, Nguyen W, et al. Phototherapy in cancer treatment: strategies and challenges. Signal Transduct Target Ther. 2025;10(1):115. https:\/\/doi.org\/10.1038\/s41392-025-02140-y.","journal-title":"Signal Transduct Target Ther"},{"issue":"24","key":"3883_CR20","doi-asserted-by":"publisher","first-page":"5855","DOI":"10.3390\/molecules29245855","volume":"29","author":"S Hong","year":"2024","unstructured":"Hong S, Park J, Oh Y, Cho H, Kim K. Nanotechnology-based strategies for safe and effective immunotherapy. Molecules. 2024;29(24):5855. https:\/\/doi.org\/10.3390\/molecules29245855.","journal-title":"Molecules"},{"issue":"34","key":"3883_CR21","doi-asserted-by":"publisher","DOI":"10.1002\/smll.202202728","volume":"18","author":"X Huang","year":"2022","unstructured":"Huang X, Gao M, Xing H, et al. Rationally designed heptamethine cyanine photosensitizers that amplify tumor-specific endoplasmic reticulum stress and boost antitumor immunity. Small. 2022;18(34):e2202728. https:\/\/doi.org\/10.1002\/smll.202202728.","journal-title":"Small"},{"issue":"22","key":"3883_CR22","doi-asserted-by":"publisher","DOI":"10.1002\/adhm.202300167","volume":"12","author":"J Zhang","year":"2023","unstructured":"Zhang J, Peng L, Hao Y, Yang H, Zhao W, Mao C. Biodegradable CuMoO4 nanodots with multienzyme activities for multimodal treatment of tumor. Adv Healthc Mater. 2023;12(22):e2300167. https:\/\/doi.org\/10.1002\/adhm.202300167.","journal-title":"Adv Healthc Mater"},{"issue":"6","key":"3883_CR23","doi-asserted-by":"publisher","first-page":"9428","DOI":"10.1021\/acsnano.2c02314","volume":"16","author":"C Ji","year":"2022","unstructured":"Ji C, Zhao M, Wang C, et al. Biocompatible tantalum nanoparticles as radiosensitizers for enhancing therapy efficacy in primary tumor and metastatic Sentinel lymph nodes. ACS Nano. 2022;16(6):9428\u201341. https:\/\/doi.org\/10.1021\/acsnano.2c02314.","journal-title":"ACS Nano"},{"issue":"15","key":"3883_CR24","doi-asserted-by":"publisher","first-page":"14800","DOI":"10.1021\/acsnano.3c03005","volume":"17","author":"G Zhang","year":"2023","unstructured":"Zhang G, Chen X, Chen X, et al. Click-reaction-mediated chemotherapy and photothermal therapy synergistically inhibit breast cancer in mice. ACS Nano. 2023;17(15):14800\u201313. https:\/\/doi.org\/10.1021\/acsnano.3c03005.","journal-title":"ACS Nano"},{"key":"3883_CR25","doi-asserted-by":"publisher","first-page":"454","DOI":"10.1016\/j.actbio.2022.10.008","volume":"154","author":"L Li","year":"2022","unstructured":"Li L, Zhang M, Liu T, et al. Quercetin-ferrum nanoparticles enhance photothermal therapy by modulating the tumor immunosuppressive microenvironment. Acta Biomater. 2022;154:454\u201366. https:\/\/doi.org\/10.1016\/j.actbio.2022.10.008.","journal-title":"Acta Biomater"},{"issue":"48","key":"3883_CR26","doi-asserted-by":"publisher","DOI":"10.1002\/smll.202304032","volume":"19","author":"G Chen","year":"2023","unstructured":"Chen G, Yang Z, Du J, et al. Topological regulating bismuth nano-semiconductor for immunogenic cell death-mediated sonocatalytic hyperthermia therapy. Small. 2023;19(48):e2304032. https:\/\/doi.org\/10.1002\/smll.202304032.","journal-title":"Small"},{"issue":"2","key":"3883_CR27","doi-asserted-by":"publisher","first-page":"1524","DOI":"10.1021\/acsabm.0c01397","volume":"4","author":"Y Duan","year":"2021","unstructured":"Duan Y, Yang H, Gao J, et al. Immune modulator and low-temperature PTT-induced synergistic immunotherapy for cancer treatment. ACS Appl Bio Mater. 2021;4(2):1524\u201335. https:\/\/doi.org\/10.1021\/acsabm.0c01397.","journal-title":"ACS Appl Bio Mater"},{"issue":"Pt 1","key":"3883_CR28","doi-asserted-by":"publisher","first-page":"116526","DOI":"10.1016\/j.envres.2023.116526","volume":"236","author":"R Malekzadeh","year":"2023","unstructured":"Malekzadeh R, Mortezazadeh T, Abdulsahib WK, et al. Nanoarchitecture-based photothermal ablation of cancer: A systematic review. Environ Res. 2023;236(Pt 1):116526. https:\/\/doi.org\/10.1016\/j.envres.2023.116526.","journal-title":"Environ Res"},{"issue":"5","key":"3883_CR29","doi-asserted-by":"publisher","first-page":"1013","DOI":"10.3390\/pharmaceutics14051013","volume":"14","author":"VO Shipunova","year":"2022","unstructured":"Shipunova VO, Belova MM, Kotelnikova PA, et al. Photothermal therapy with HER2-targeted silver nanoparticles leading to cancer remission. Pharmaceutics. 2022;14(5):1013. https:\/\/doi.org\/10.3390\/pharmaceutics14051013. (Published 2022 May 8).","journal-title":"Pharmaceutics"},{"issue":"4","key":"3883_CR30","doi-asserted-by":"publisher","first-page":"6517","DOI":"10.1021\/acsnano.0c08790","volume":"15","author":"Y Zhao","year":"2021","unstructured":"Zhao Y, Zhao T, Cao Y, et al. Temperature-sensitive lipid-coated carbon nanotubes for synergistic photothermal therapy and gene therapy. ACS Nano. 2021;15(4):6517\u201329. https:\/\/doi.org\/10.1021\/acsnano.0c08790.","journal-title":"ACS Nano"},{"issue":"22","key":"3883_CR31","doi-asserted-by":"publisher","DOI":"10.1002\/adma.202008481","volume":"33","author":"J Li","year":"2021","unstructured":"Li J, Xie L, Li B, et al. Engineering a hydrogen-sulfide-based nanomodulator to normalize hyperactive photothermal immunogenicity for combination cancer therapy. Adv Mater. 2021;33(22):e2008481. https:\/\/doi.org\/10.1002\/adma.202008481.","journal-title":"Adv Mater"},{"issue":"25","key":"3883_CR32","doi-asserted-by":"publisher","first-page":"23056","DOI":"10.1021\/acsomega.3c02370","volume":"8","author":"Z Liu","year":"2023","unstructured":"Liu Z, Xie H, Wang T. Erythrocyte-cancer hybrid membrane-camouflaged Prussian blue nanoparticles with enhanced photothermal therapy in tumors. ACS Omega. 2023;8(25):23056\u201366. https:\/\/doi.org\/10.1021\/acsomega.3c02370. (Published 2023 Jun 9).","journal-title":"ACS Omega"},{"issue":"1","key":"3883_CR33","doi-asserted-by":"publisher","first-page":"222","DOI":"10.1186\/s12951-022-01402-z","volume":"20","author":"M Alle","year":"2022","unstructured":"Alle M, Sharma G, Lee SH, Kim JC. Next-generation engineered nanogold for multimodal cancer therapy and imaging: a clinical perspectives. J Nanobiotechnol. 2022;20(1):222. https:\/\/doi.org\/10.1186\/s12951-022-01402-z. (Published 2022 Jul 2).","journal-title":"J Nanobiotechnol"},{"issue":"1","key":"3883_CR34","doi-asserted-by":"publisher","first-page":"91","DOI":"10.22037\/ijpr.2019.112339.13697","volume":"20","author":"MA Behnam","year":"2021","unstructured":"Behnam MA, Emami F, Sobhani Z. PEGylated carbon nanotubes decorated with silver nanoparticles: fabrication, cell cytotoxicity and application in photo thermal therapy. Iran J Pharm Res. 2021;20(1):91\u2013104. https:\/\/doi.org\/10.22037\/ijpr.2019.112339.13697.","journal-title":"Iran J Pharm Res"},{"issue":"5","key":"3883_CR35","doi-asserted-by":"publisher","DOI":"10.1002\/EXP.20220161","volume":"3","author":"J Ma","year":"2023","unstructured":"Ma J, Li N, Wang J, Liu Z, Han Y, Zeng Y. In vivo synergistic tumor therapies based on copper sulfide photothermal therapeutic nanoplatforms. Exploration. 2023;3(5):20220161. https:\/\/doi.org\/10.1002\/EXP.20220161.","journal-title":"Exploration"},{"issue":"1","key":"3883_CR36","doi-asserted-by":"publisher","first-page":"92","DOI":"10.1016\/j.apsb.2021.08.012","volume":"12","author":"S Fu","year":"2022","unstructured":"Fu S, Li G, Zang W, Zhou X, Shi K, Zhai Y. Pure drug nano-assemblies: a facile carrier-free nanoplatform for efficient cancer therapy. Acta Pharm Sin B. 2022;12(1):92\u2013106. https:\/\/doi.org\/10.1016\/j.apsb.2021.08.012.","journal-title":"Acta Pharm Sin B"},{"issue":"15","key":"3883_CR37","doi-asserted-by":"publisher","first-page":"3569","DOI":"10.1039\/d3tb02797j","volume":"12","author":"S Thirumurugan","year":"2024","unstructured":"Thirumurugan S, Ramanathan S, Muthiah KS, et al. Inorganic nanoparticles for photothermal treatment of cancer. J Mater Chem B. 2024;12(15):3569\u201393. https:\/\/doi.org\/10.1039\/d3tb02797j.","journal-title":"J Mater Chem B"},{"key":"3883_CR38","doi-asserted-by":"publisher","DOI":"10.34133\/2021\/9816594","volume":"2021","author":"X Yi","year":"2021","unstructured":"Yi X, Duan QY, Wu FG. Low-temperature photothermal therapy: strategies and applications. Research (Wash D C). 2021;2021:9816594. https:\/\/doi.org\/10.34133\/2021\/9816594.","journal-title":"Research (Wash D C)"},{"issue":"11","key":"3883_CR39","doi-asserted-by":"publisher","DOI":"10.1002\/adma.201907855","volume":"32","author":"D Xi","year":"2020","unstructured":"Xi D, Xiao M, Cao J, et al. NIR light-driving barrier-free group rotation in nanoparticles with an 88.3% photothermal conversion efficiency for photothermal therapy. Adv Mater. 2020;32(11):e1907855. https:\/\/doi.org\/10.1002\/adma.201907855.","journal-title":"Adv Mater"},{"key":"3883_CR40","doi-asserted-by":"publisher","first-page":"161","DOI":"10.1007\/978-1-0716-2651-1_16","volume":"2560","author":"DO Baddam","year":"2023","unstructured":"Baddam DO, Ragi SD, Tsang SH, Ngo WK. Protocol for indocyanine green angiography. Methods Mol Biol. 2023;2560:161\u20137. https:\/\/doi.org\/10.1007\/978-1-0716-2651-1_16.","journal-title":"Methods Mol Biol"},{"key":"3883_CR41","doi-asserted-by":"publisher","DOI":"10.3389\/fimmu.2023.1279221","volume":"14","author":"G Xiao","year":"2023","unstructured":"Xiao G, Zhao Y, Wang X, Zeng C, Luo F, Jing J. Photothermally sensitive gold nanocage augments the antitumor efficiency of immune checkpoint blockade in immune \u201ccold\u201d tumors. Front Immunol. 2023;14:1279221. https:\/\/doi.org\/10.3389\/fimmu.2023.1279221.","journal-title":"Front Immunol"},{"issue":"10","key":"3883_CR42","doi-asserted-by":"publisher","first-page":"3244","DOI":"10.1016\/j.apsb.2021.05.005","volume":"11","author":"H Ren","year":"2021","unstructured":"Ren H, Yong J, Yang Q, et al. Self-assembled FeS-based cascade bioreactor with enhanced tumor penetration and synergistic treatments to trigger robust cancer immunotherapy. Acta Pharm Sin B. 2021;11(10):3244\u201361. https:\/\/doi.org\/10.1016\/j.apsb.2021.05.005.","journal-title":"Acta Pharm Sin B"},{"issue":"1","key":"3883_CR43","doi-asserted-by":"publisher","first-page":"64","DOI":"10.1186\/s12951-023-01818-1","volume":"21","author":"K Liu","year":"2023","unstructured":"Liu K, Zhang L, Lu H, et al. Enhanced mild-temperature photothermal therapy by pyroptosis-boosted ATP deprivation with biodegradable nanoformulation. J Nanobiotechnol. 2023;21(1):64. https:\/\/doi.org\/10.1186\/s12951-023-01818-1. Published 2023 Feb 23.","journal-title":"J Nanobiotechnol"},{"issue":"1","key":"3883_CR44","doi-asserted-by":"publisher","first-page":"97","DOI":"10.1186\/s12951-024-02297-8","volume":"22","author":"W Deng","year":"2024","unstructured":"Deng W, Shang H, Tong Y, et al. The application of nanoparticles-based ferroptosis, pyroptosis and autophagy in cancer immunotherapy. J Nanobiotechnol. 2024;22(1):97. https:\/\/doi.org\/10.1186\/s12951-024-02297-8.","journal-title":"J Nanobiotechnol"},{"issue":"2","key":"3883_CR45","doi-asserted-by":"publisher","first-page":"817","DOI":"10.7150\/thno.67932","volume":"12","author":"Q Zeng","year":"2022","unstructured":"Zeng Q, Ma X, Song Y, Chen Q, Jiao Q, Zhou L. Targeting regulated cell death in tumor nanomedicines. Theranostics. 2022;12(2):817\u201341. https:\/\/doi.org\/10.7150\/thno.67932.","journal-title":"Theranostics"},{"issue":"38","key":"3883_CR46","doi-asserted-by":"publisher","first-page":"42988","DOI":"10.1021\/acsami.2c12969","volume":"14","author":"X Yu","year":"2022","unstructured":"Yu X, Han N, Dong Z, et al. Combined chemo-immuno-photothermal therapy for effective cancer treatment via an all-in-one and one-for-all nanoplatform. ACS Appl Mater Interfaces. 2022;14(38):42988\u20133009. https:\/\/doi.org\/10.1021\/acsami.2c12969.","journal-title":"ACS Appl Mater Interfaces"},{"issue":"4","key":"3883_CR47","doi-asserted-by":"publisher","DOI":"10.1002\/adhm.202302095","volume":"13","author":"G Zhu","year":"2024","unstructured":"Zhu G, Zheng P, Wang M, et al. Near-infrared light-triggered thermoresponsive pyroptosis system for synergistic tumor immunotherapy. Adv Healthc Mater. 2024;13(4):e2302095. https:\/\/doi.org\/10.1002\/adhm.202302095.","journal-title":"Adv Healthc Mater"},{"issue":"5","key":"3883_CR48","doi-asserted-by":"publisher","first-page":"521","DOI":"10.1002\/cac2.12539","volume":"44","author":"GR Khosravi","year":"2024","unstructured":"Khosravi GR, Mostafavi S, Bastan S, Ebrahimi N, Gharibvand RS, Eskandari N. Immunologic tumor microenvironment modulators for turning cold tumors hot. Cancer Commun (Lond). 2024;44(5):521\u201353. https:\/\/doi.org\/10.1002\/cac2.12539.","journal-title":"Cancer Commun (Lond)"},{"key":"3883_CR49","doi-asserted-by":"publisher","first-page":"121425","DOI":"10.1016\/j.biomaterials.2022.121425","volume":"282","author":"R Guo","year":"2022","unstructured":"Guo R, Wang S, Zhao L, et al. Engineered nanomaterials for synergistic photo-immunotherapy. Biomaterials. 2022;282:121425. https:\/\/doi.org\/10.1016\/j.biomaterials.2022.121425.","journal-title":"Biomaterials"},{"key":"3883_CR50","doi-asserted-by":"publisher","first-page":"121130","DOI":"10.1016\/j.biomaterials.2021.121130","volume":"277","author":"D Hu","year":"2021","unstructured":"Hu D, Xu H, Zhang W, et al. Vanadyl nanocomplexes enhance photothermia-induced cancer immunotherapy to inhibit tumor metastasis and recurrence. Biomaterials. 2021;277:121130. https:\/\/doi.org\/10.1016\/j.biomaterials.2021.121130.","journal-title":"Biomaterials"},{"issue":"25","key":"3883_CR51","doi-asserted-by":"publisher","first-page":"7764","DOI":"10.1021\/acs.nanolett.4c01879","volume":"24","author":"Z Huang","year":"2024","unstructured":"Huang Z, Song J, Huang S, et al. Phase and defect engineering of MoSe2 nanosheets for enhanced NIR-II photothermal immunotherapy. Nano Lett. 2024;24(25):7764\u201373. https:\/\/doi.org\/10.1021\/acs.nanolett.4c01879.","journal-title":"Nano Lett"},{"issue":"1","key":"3883_CR52","doi-asserted-by":"publisher","first-page":"347","DOI":"10.1186\/s12967-022-03554-w","volume":"20","author":"EE Abd El-Fattah","year":"2022","unstructured":"Abd El-Fattah EE. IDO\/kynurenine pathway in cancer: possible therapeutic approaches. J Transl Med. 2022;20(1):347. https:\/\/doi.org\/10.1186\/s12967-022-03554-w. Published 2022 Aug 2.","journal-title":"J Transl Med"},{"issue":"1","key":"3883_CR53","doi-asserted-by":"publisher","first-page":"241","DOI":"10.1186\/s12943-024-02164-y","volume":"23","author":"J Yan","year":"2024","unstructured":"Yan J, Chen D, Ye Z, et al. Molecular mechanisms and therapeutic significance of tryptophan metabolism and signaling in cancer. Mol Cancer. 2024;23(1):241. https:\/\/doi.org\/10.1186\/s12943-024-02164-y. (Published 2024 Oct 30).","journal-title":"Mol Cancer"},{"issue":"24","key":"3883_CR54","doi-asserted-by":"publisher","first-page":"30671","DOI":"10.1021\/acsami.4c02740","volume":"16","author":"X Wang","year":"2024","unstructured":"Wang X, Yan B, Li H, et al. Reprogrammed IDO-induced immunosuppressive microenvironment synergizes with immunogenic magnetothermodynamics for improved cancer therapy. ACS Appl Mater Interfaces. 2024;16(24):30671\u201384. https:\/\/doi.org\/10.1021\/acsami.4c02740.","journal-title":"ACS Appl Mater Interfaces"},{"issue":"1","key":"3883_CR55","doi-asserted-by":"publisher","first-page":"5644","DOI":"10.1038\/s41467-022-33285-x","volume":"13","author":"D Shi","year":"2022","unstructured":"Shi D, Wu X, Jian Y, et al. USP14 promotes tryptophan metabolism and immune suppression by stabilizing IDO1 in colorectal cancer. Nat Commun. 2022;13(1):5644. https:\/\/doi.org\/10.1038\/s41467-022-33285-x. (Published 2022 Sep 26).","journal-title":"Nat Commun"},{"issue":"5","key":"3883_CR56","doi-asserted-by":"publisher","DOI":"10.1002\/advs.201700891","volume":"5","author":"J Peng","year":"2018","unstructured":"Peng J, Xiao Y, Li W, et al. Photosensitizer micelles together with IDO inhibitor enhance cancer photothermal therapy and immunotherapy. Adv Sci. 2018;5(5):1700891. https:\/\/doi.org\/10.1002\/advs.201700891.","journal-title":"Adv Sci"},{"issue":"14","key":"3883_CR57","doi-asserted-by":"publisher","DOI":"10.1002\/advs.202100165","volume":"8","author":"W Hu","year":"2021","unstructured":"Hu W, Xiao T, Li D, et al. Intelligent molybdenum disulfide complexes as a platform for cooperative imaging-guided tri-mode chemo-photothermo-immunotherapy. Adv Sci. 2021;8(14):e2100165. https:\/\/doi.org\/10.1002\/advs.202100165.","journal-title":"Adv Sci"},{"issue":"32","key":"3883_CR58","doi-asserted-by":"publisher","DOI":"10.1002\/advs.202204067","volume":"9","author":"L Wang","year":"2022","unstructured":"Wang L, Jiang W, Su Y, et al. Self-splittable transcytosis nanoraspberry for NIR-II photo-immunometabolic cancer therapy in deep tumor tissue. Adv Sci. 2022;9(32):e2204067. https:\/\/doi.org\/10.1002\/advs.202204067.","journal-title":"Adv Sci"},{"issue":"1","key":"3883_CR59","doi-asserted-by":"publisher","first-page":"44","DOI":"10.1186\/s12943-023-01733-x","volume":"22","author":"C Xia","year":"2023","unstructured":"Xia C, Yin S, To KKW, Fu L. CD39\/CD73\/A2AR pathway and cancer immunotherapy. Mol Cancer. 2023;22(1):44. https:\/\/doi.org\/10.1186\/s12943-023-01733-x. Published 2023 Mar 2.","journal-title":"Mol Cancer"},{"issue":"7","key":"3883_CR60","doi-asserted-by":"publisher","first-page":"2009","DOI":"10.1007\/s00262-020-02843-x","volume":"70","author":"T Kamai","year":"2021","unstructured":"Kamai T, Kijima T, Tsuzuki T, et al. Increased expression of adenosine 2A receptors in metastatic renal cell carcinoma is associated with poorer response to anti-vascular endothelial growth factor agents and anti-PD-1\/Anti-CTLA4 antibodies and shorter survival. Cancer Immunol Immunother. 2021;70(7):2009\u201321. https:\/\/doi.org\/10.1007\/s00262-020-02843-x.","journal-title":"Cancer Immunol Immunother"},{"issue":"8","key":"3883_CR61","doi-asserted-by":"publisher","DOI":"10.1002\/adma.202419120","volume":"37","author":"Q Xiang","year":"2025","unstructured":"Xiang Q, Yang X, Zhang Z, et al. Fe\/Mo-based lipid peroxidation nanoamplifier combined with adenosine immunometabolism regulation to augment anti-breast cancer immunity. Adv Mater. 2025;37(8):e2419120. https:\/\/doi.org\/10.1002\/adma.202419120.","journal-title":"Adv Mater"},{"issue":"14","key":"3883_CR62","doi-asserted-by":"publisher","DOI":"10.1002\/advs.202104182","volume":"9","author":"Y Liu","year":"2022","unstructured":"Liu Y, Liu Y, Xu D, et al. Targeting the negative feedback of adenosine-A2AR metabolic pathway by a tailored nanoinhibitor for photothermal immunotherapy. Adv Sci. 2022;9(14):e2104182. https:\/\/doi.org\/10.1002\/advs.202104182.","journal-title":"Adv Sci"},{"issue":"8","key":"3883_CR63","doi-asserted-by":"publisher","DOI":"10.1002\/advs.202104793","volume":"9","author":"Z Wang","year":"2022","unstructured":"Wang Z, Yu L, Wang Y, et al. Dynamic adjust of non-radiative and radiative attenuation of AIE molecules reinforces NIR-II imaging mediated photothermal therapy and immunotherapy. Adv Sci. 2022;9(8):e2104793. https:\/\/doi.org\/10.1002\/advs.202104793.","journal-title":"Adv Sci"},{"issue":"1","key":"3883_CR64","doi-asserted-by":"publisher","first-page":"353","DOI":"10.1186\/s40001-024-01901-9","volume":"29","author":"M Jama","year":"2024","unstructured":"Jama M, Tabana Y, Barakat KH. Targeting cytotoxic lymphocyte antigen 4 (CTLA-4) in breast cancer. Eur J Med Res. 2024;29(1):353. https:\/\/doi.org\/10.1186\/s40001-024-01901-9. Published 2024 Jul 2.","journal-title":"Eur J Med Res"},{"key":"3883_CR65","doi-asserted-by":"publisher","DOI":"10.1016\/j.intimp.2020.106221","volume":"80","author":"A Hosseini","year":"2020","unstructured":"Hosseini A, Gharibi T, Marofi F, Babaloo Z, Baradaran B. CTLA-4: from mechanism to autoimmune therapy. Int Immunopharmacol. 2020;80:106221. https:\/\/doi.org\/10.1016\/j.intimp.2020.106221.","journal-title":"Int Immunopharmacol"},{"issue":"1","key":"3883_CR66","doi-asserted-by":"publisher","first-page":"4","DOI":"10.1016\/j.tips.2019.11.003","volume":"41","author":"Y Liu","year":"2020","unstructured":"Liu Y, Zheng P. Preserving the CTLA-4 checkpoint for safer and more effective cancer immunotherapy. Trends Pharmacol Sci. 2020;41(1):4\u201312. https:\/\/doi.org\/10.1016\/j.tips.2019.11.003.","journal-title":"Trends Pharmacol Sci"},{"key":"3883_CR67","doi-asserted-by":"publisher","unstructured":"Cano-Mejia J, Burga RA, Sweeney EE, et al. Prussian blue nanoparticle-based photothermal therapy combined with checkpoint inhibition for photothermal immunotherapy of neuroblastoma. Nanomedicine. 2017(2). https:\/\/doi.org\/10.1016\/j.nano.2016.10.015.","DOI":"10.1016\/j.nano.2016.10.015"},{"key":"3883_CR68","doi-asserted-by":"publisher","first-page":"44","DOI":"10.1016\/j.nano.2019.02.009","volume":"18","author":"Y Li","year":"2019","unstructured":"Li Y, Li X, Doughty A, et al. Phototherapy using immunologically modified carbon nanotubes to potentiate checkpoint blockade for metastatic breast cancer. Nanomedicine. 2019;18:44\u201353. https:\/\/doi.org\/10.1016\/j.nano.2019.02.009.","journal-title":"Nanomedicine"},{"issue":"10","key":"3883_CR69","doi-asserted-by":"publisher","DOI":"10.1016\/j.tranon.2020.100823","volume":"13","author":"J Cano-Mejia","year":"2020","unstructured":"Cano-Mejia J, Shukla A, Ledezma DK, Palmer E, Villagra A, Fernandes R. CpG-coated prussian blue nanoparticles-based photothermal therapy combined with anti-CTLA-4 immune checkpoint blockade triggers a robust abscopal effect against neuroblastoma. Transl Oncol. 2020;(10):100823. https:\/\/doi.org\/10.1016\/j.tranon.2020.100823.","journal-title":"Transl Oncol"},{"key":"3883_CR70","doi-asserted-by":"publisher","DOI":"10.1016\/j.smim.2021.101480","volume":"52","author":"KE Pauken","year":"2021","unstructured":"Pauken KE, Torchia JA, Chaudhri A, Sharpe AH, Freeman GJ. Emerging concepts in PD-1 checkpoint biology. Semin Immunol. 2021;52:101480. https:\/\/doi.org\/10.1016\/j.smim.2021.101480.","journal-title":"Semin Immunol"},{"key":"3883_CR71","doi-asserted-by":"publisher","first-page":"874589","DOI":"10.3389\/fimmu.2022.874589","volume":"13","author":"Y Pu","year":"2022","unstructured":"Pu Y, Ji Q. Tumor-associated macrophages regulate PD-1\/PD-L1 immunosuppression. Front Immunol. 2022;13:874589. https:\/\/doi.org\/10.3389\/fimmu.2022.874589. (Published 2022 May 3).","journal-title":"Front Immunol"},{"key":"3883_CR72","doi-asserted-by":"publisher","first-page":"150","DOI":"10.1016\/j.jconrel.2019.01.027","volume":"296","author":"X Liang","year":"2019","unstructured":"Liang X, Ye X, Wang C, et al. Photothermal cancer immunotherapy by erythrocyte membrane-coated black phosphorus formulation. J Control Release. 2019;296:150\u201361. https:\/\/doi.org\/10.1016\/j.jconrel.2019.01.027.","journal-title":"J Control Release"},{"issue":"1","key":"3883_CR73","doi-asserted-by":"publisher","first-page":"433","DOI":"10.1186\/s12951-021-01197-5","volume":"19","author":"H Sun","year":"2021","unstructured":"Sun H, Yu T, Li X, et al. Second near-infrared photothermal-amplified immunotherapy using photoactivatable composite nanostimulators. J Nanobiotechnol. 2021;19(1):433. https:\/\/doi.org\/10.1186\/s12951-021-01197-5. Published 2021 Dec 20.","journal-title":"J Nanobiotechnol"},{"key":"3883_CR74","doi-asserted-by":"publisher","first-page":"621","DOI":"10.1016\/j.actbio.2021.07.051","volume":"134","author":"S Wang","year":"2021","unstructured":"Wang S, Song Y, Cao K, et al. Photothermal therapy mediated by gold nanocages composed of anti-PDL1 and galunisertib for improved synergistic immunotherapy in colorectal cancer. Acta Biomater. 2021;134:621\u201332. https:\/\/doi.org\/10.1016\/j.actbio.2021.07.051.","journal-title":"Acta Biomater"},{"issue":"Suppl 3","key":"3883_CR75","doi-asserted-by":"publisher","DOI":"10.1136\/esmoopen-2020-000733","volume":"4","author":"I Etxeberria","year":"2020","unstructured":"Etxeberria I, Glez-Vaz J, Teijeira \u00c1, Melero I. New emerging targets in cancer immunotherapy: CD137\/4-1BB costimulatory axis. ESMO Open. 2020;4(Suppl 3):e000733. https:\/\/doi.org\/10.1136\/esmoopen-2020-000733.","journal-title":"ESMO Open"},{"issue":"3","key":"3883_CR76","doi-asserted-by":"publisher","first-page":"552","DOI":"10.1158\/2159-8290.CD-22-1029","volume":"13","author":"I Melero","year":"2023","unstructured":"Melero I, Sanmamed MF, Glez-Vaz J, Luri-Rey C, Wang J, Chen L. CD137 (4-1BB)-based cancer immunotherapy on its 25th anniversary. Cancer Discov. 2023;13(3):552\u201369. https:\/\/doi.org\/10.1158\/2159-8290.CD-22-1029.","journal-title":"Cancer Discov"},{"issue":"3","key":"3883_CR77","doi-asserted-by":"publisher","first-page":"2300","DOI":"10.1007\/s12274-021-3813-1","volume":"15","author":"PB Balakrishnan","year":"2022","unstructured":"Balakrishnan PB, Ledezma DK, Cano-Mejia J, et al. CD137 agonist potentiates the abscopal efficacy of nanoparticle-based photothermal therapy for melanoma. Nano Res. 2022;15(3):2300\u201314. https:\/\/doi.org\/10.1007\/s12274-021-3813-1.","journal-title":"Nano Res"},{"issue":"28","key":"3883_CR78","doi-asserted-by":"publisher","first-page":"5659","DOI":"10.2174\/0929867328666201229123151","volume":"28","author":"X Lu","year":"2021","unstructured":"Lu X. OX40 and OX40L interaction in cancer. Curr Med Chem. 2021;28(28):5659\u201373. https:\/\/doi.org\/10.2174\/0929867328666201229123151.","journal-title":"Curr Med Chem"},{"issue":"1","key":"3883_CR79","doi-asserted-by":"publisher","first-page":"81","DOI":"10.1080\/13543776.2021.1825688","volume":"31","author":"J Cebada","year":"2021","unstructured":"Cebada J, Perez-Santos M, Bandala C, et al. OX40 agonists for cancer treatment: a patent review. Expert Opin Ther Pat. 2021;31(1):81\u201390. https:\/\/doi.org\/10.1080\/13543776.2021.1825688.","journal-title":"Expert Opin Ther Pat"},{"issue":"1","key":"3883_CR80","doi-asserted-by":"publisher","first-page":"306","DOI":"10.1053\/j.gastro.2020.03.018","volume":"159","author":"Y Ma","year":"2020","unstructured":"Ma Y, Li J, Wang H, et al. Combination of PD-1 inhibitor and OX40 agonist induces tumor rejection and immune memory in mouse models of pancreatic cancer. Gastroenterology. 2020;159(1):306-319.e12. https:\/\/doi.org\/10.1053\/j.gastro.2020.03.018.","journal-title":"Gastroenterology"},{"issue":"18","key":"3883_CR81","doi-asserted-by":"publisher","first-page":"7796","DOI":"10.1021\/acs.nanolett.1c02782","volume":"21","author":"W Ni","year":"2021","unstructured":"Ni W, Wu J, Fang H, et al. Photothermal-chemotherapy enhancing tumor immunotherapy by multifunctional metal-organic framework based drug delivery system. Nano Lett. 2021;21(18):7796\u2013805. https:\/\/doi.org\/10.1021\/acs.nanolett.1c02782.","journal-title":"Nano Lett"},{"issue":"1","key":"3883_CR82","doi-asserted-by":"publisher","first-page":"445","DOI":"10.3892\/mmr.2019.10816","volume":"21","author":"M Liu","year":"2020","unstructured":"Liu M, Li Z, Yao W, et al. IDO inhibitor synergized with radiotherapy to delay tumor growth by reversing T cell exhaustion. Mol Med Rep. 2020;21(1):445\u201353. https:\/\/doi.org\/10.3892\/mmr.2019.10816.","journal-title":"Mol Med Rep"},{"key":"3883_CR83","doi-asserted-by":"publisher","first-page":"837230","DOI":"10.3389\/fimmu.2022.837230","volume":"13","author":"C Sun","year":"2022","unstructured":"Sun C, Wang B, Hao S. Adenosine-A2A receptor pathway in cancer immunotherapy. Front Immunol. 2022;13:837230. https:\/\/doi.org\/10.3389\/fimmu.2022.837230. Published 2022 Mar 21.","journal-title":"Front Immunol"},{"key":"3883_CR84","doi-asserted-by":"publisher","first-page":"7","DOI":"10.1007\/978-981-15-3266-5_2","volume":"1248","author":"S Van Coillie","year":"2020","unstructured":"Van Coillie S, Wiernicki B, Xu J. Molecular and cellular functions of CTLA-4. Adv Exp Med Biol. 2020;1248:7\u201332. https:\/\/doi.org\/10.1007\/978-981-15-3266-5_2.","journal-title":"Adv Exp Med Biol"},{"issue":"20","key":"3883_CR85","doi-asserted-by":"publisher","first-page":"9999","DOI":"10.1073\/pnas.1822001116","volume":"116","author":"T Kamada","year":"2019","unstructured":"Kamada T, Togashi Y, Tay C, et al. PD-1\u2009+\u2009regulatory T cells amplified by PD-1 blockade promote hyperprogression of cancer. Proc Natl Acad Sci U S A. 2019;116(20):9999\u201310008. https:\/\/doi.org\/10.1073\/pnas.1822001116.","journal-title":"Proc Natl Acad Sci U S A"},{"issue":"7","key":"3883_CR86","doi-asserted-by":"publisher","first-page":"1631","DOI":"10.1016\/j.immuni.2023.06.007","volume":"56","author":"AC Pichler","year":"2023","unstructured":"Pichler AC, Carri\u00e9 N, Cuisinier M, et al. TCR-independent CD137 (4-1BB) signaling promotes CD8+-exhausted T cell proliferation and terminal differentiation. Immunity. 2023;56(7):1631-1648.e10. https:\/\/doi.org\/10.1016\/j.immuni.2023.06.007.","journal-title":"Immunity"},{"key":"3883_CR87","doi-asserted-by":"publisher","first-page":"184","DOI":"10.1016\/j.jconrel.2024.09.044","volume":"376","author":"Z Zhang","year":"2024","unstructured":"Zhang Z, Lu Y, Liu W, Huang Y. Nanomaterial-assisted delivery of CpG oligodeoxynucleotides for boosting cancer immunotherapy. J Control Release. 2024;376:184\u201399. https:\/\/doi.org\/10.1016\/j.jconrel.2024.09.044.","journal-title":"J Control Release"},{"key":"3883_CR88","doi-asserted-by":"publisher","DOI":"10.1016\/j.lfs.2022.120874","volume":"307","author":"MM Saber","year":"2022","unstructured":"Saber MM, Monir N, Awad AS, Elsherbiny ME, Zaki HF. TLR9: a friend or a foe. Life Sci. 2022;307:120874. https:\/\/doi.org\/10.1016\/j.lfs.2022.120874.","journal-title":"Life Sci"},{"issue":"5","key":"3883_CR89","doi-asserted-by":"publisher","first-page":"555","DOI":"10.1016\/j.pathol.2025.05.001","volume":"57","author":"V Lea","year":"2025","unstructured":"Lea V, Lim SH, Lee CS. Oncogenic mutations of clinical significance in colorectal cancer. Pathology. 2025;57(5):555\u201363. https:\/\/doi.org\/10.1016\/j.pathol.2025.05.001.","journal-title":"Pathology"},{"issue":"3","key":"3883_CR90","doi-asserted-by":"publisher","first-page":"860","DOI":"10.7150\/thno.19826","volume":"8","author":"L Li","year":"2018","unstructured":"Li L, Yang S, Song L, et al. An endogenous vaccine based on fluorophores and multivalent immunoadjuvants regulates tumor micro-environment for synergistic photothermal and immunotherapy. Theranostics. 2018;8(3):860\u201373. https:\/\/doi.org\/10.7150\/thno.19826. (Published 2018 Jan 1).","journal-title":"Theranostics"},{"issue":"15","key":"3883_CR91","doi-asserted-by":"publisher","first-page":"4581","DOI":"10.1182\/bloodadvances.2022008040","volume":"6","author":"AY Lin","year":"2022","unstructured":"Lin AY, Choi B, Sim T, et al. Enhanced systemic antilymphoma immune response by photothermal therapy with CpG deoxynucleotide-coated nanoparticles. Blood Adv. 2022;6(15):4581\u201392. https:\/\/doi.org\/10.1182\/bloodadvances.2022008040.","journal-title":"Blood Adv"},{"key":"3883_CR92","doi-asserted-by":"publisher","first-page":"1418025","DOI":"10.3389\/fimmu.2024.1418025","volume":"15","author":"J Zhou","year":"2024","unstructured":"Zhou J, Zhang L, Liu S, DeRubeis D, Zhang D. Toll-like receptors in breast cancer immunity and immunotherapy. Front Immunol. 2024;15:1418025. https:\/\/doi.org\/10.3389\/fimmu.2024.1418025. Published 2024 Jun 6.","journal-title":"Front Immunol"},{"issue":"15","key":"3883_CR93","doi-asserted-by":"publisher","DOI":"10.3390\/cancers16152679","volume":"16","author":"U Al-Alem","year":"2024","unstructured":"Al-Alem U, Al-Saruri A, Bamahros H, Mahmoud AM, Sible E, Hasan UA. Understanding the role of toll-like receptors 9 in breast cancer. Cancers (Basel). 2024;16(15):2679. https:\/\/doi.org\/10.3390\/cancers16152679.","journal-title":"Cancers (Basel)"},{"issue":"20","key":"3883_CR94","doi-asserted-by":"publisher","DOI":"10.3390\/cancers15205104","volume":"15","author":"M Majewski","year":"2023","unstructured":"Majewski M, Mertowska P, Mertowski S, Torres K, Grywalska E. How toll-like receptor 9 plays a key role in the development of gastric cancer and is linked to Epstein-Barr virus infection. Cancers (Basel). 2023;15(20):5104. https:\/\/doi.org\/10.3390\/cancers15205104.","journal-title":"Cancers (Basel)"},{"issue":"4","key":"3883_CR95","doi-asserted-by":"publisher","DOI":"10.1002\/adma.202003458","volume":"33","author":"J Li","year":"2021","unstructured":"Li J, Yu X, Jiang Y, et al. Second near-infrared photothermal semiconducting polymer nanoadjuvant for enhanced cancer immunotherapy. Adv Mater. 2021;33(4):e2003458. https:\/\/doi.org\/10.1002\/adma.202003458.","journal-title":"Adv Mater"},{"issue":"1","key":"3883_CR96","doi-asserted-by":"publisher","first-page":"181","DOI":"10.1186\/s12951-022-01388-8","volume":"20","author":"J Yue","year":"2022","unstructured":"Yue J, Mei Q, Wang P, Miao P, Dong WF, Li L. Light-triggered multifunctional nanoplatform for efficient cancer photo-immunotherapy. J Nanobiotechnol. 2022;20(1):181. https:\/\/doi.org\/10.1186\/s12951-022-01388-8. Published 2022 Apr 7.","journal-title":"J Nanobiotechnol"},{"issue":"15","key":"3883_CR97","doi-asserted-by":"publisher","first-page":"2770","DOI":"10.1016\/j.cell.2022.06.035","volume":"185","author":"MC Sellars","year":"2022","unstructured":"Sellars MC, Wu CJ, Fritsch EF. Cancer vaccines: building a bridge over troubled waters. Cell. 2022;185(15):2770\u201388. https:\/\/doi.org\/10.1016\/j.cell.2022.06.035.","journal-title":"Cell"},{"issue":"2","key":"3883_CR98","doi-asserted-by":"publisher","first-page":"361","DOI":"10.1039\/d2mh01358d","volume":"10","author":"Y Zhang","year":"2023","unstructured":"Zhang Y, Chen J, Shi L, Ma F. Polymeric nanoparticle-based nanovaccines for cancer immunotherapy. Mater Horiz. 2023;10(2):361\u201392. https:\/\/doi.org\/10.1039\/d2mh01358d.","journal-title":"Mater Horiz"},{"key":"3883_CR99","doi-asserted-by":"publisher","DOI":"10.1016\/j.intimp.2023.109887","volume":"117","author":"N Hashemi Goradel","year":"2023","unstructured":"Hashemi Goradel N, Nemati M, Bakhshandeh A, Arashkia A, Negahdari B. Nanovaccines for cancer immunotherapy: focusing on complex formation between adjuvant and antigen. Int Immunopharmacol. 2023;117:109887. https:\/\/doi.org\/10.1016\/j.intimp.2023.109887.","journal-title":"Int Immunopharmacol"},{"key":"3883_CR100","doi-asserted-by":"publisher","first-page":"121808","DOI":"10.1016\/j.biomaterials.2022.121808","volume":"289","author":"D Huang","year":"2022","unstructured":"Huang D, Wu T, Lan S, Liu C, Guo Z, Zhang W. In situ photothermal nano-vaccine based on tumor cell membrane-coated black phosphorus-Au for photo-immunotherapy of metastatic breast tumors. Biomaterials. 2022;289:121808. https:\/\/doi.org\/10.1016\/j.biomaterials.2022.121808.","journal-title":"Biomaterials"},{"issue":"17","key":"3883_CR101","doi-asserted-by":"publisher","DOI":"10.1002\/adhm.202203028","volume":"12","author":"Y Zhang","year":"2023","unstructured":"Zhang Y, Li Q, Ding M, et al. Endogenous\/exogenous nanovaccines synergistically enhance dendritic cell-mediated tumor immunotherapy. Adv Healthc Mater. 2023;12(17):e2203028. https:\/\/doi.org\/10.1002\/adhm.202203028.","journal-title":"Adv Healthc Mater"},{"issue":"6622","key":"3883_CR102","doi-asserted-by":"publisher","first-page":"858","DOI":"10.1126\/science.add9667","volume":"378","author":"CR Gurbatri","year":"2022","unstructured":"Gurbatri CR, Arpaia N, Danino T. Engineering bacteria as interactive cancer therapies. Science. 2022;378(6622):858\u201364. https:\/\/doi.org\/10.1126\/science.add9667.","journal-title":"Science"},{"issue":"8","key":"3883_CR103","doi-asserted-by":"publisher","first-page":"569","DOI":"10.1038\/s41571-024-00908-9","volume":"21","author":"SY Kwon","year":"2024","unstructured":"Kwon SY, Thi-Thu Ngo H, Son J, Hong Y, Min JJ. Exploiting bacteria for cancer immunotherapy. Nat Rev Clin Oncol. 2024;21(8):569\u201389. https:\/\/doi.org\/10.1038\/s41571-024-00908-9.","journal-title":"Nat Rev Clin Oncol"},{"issue":"6536","key":"3883_CR104","doi-asserted-by":"publisher","first-page":"eabc4552","DOI":"10.1126\/science.abc4552","volume":"371","author":"GD Sepich-Poore","year":"2021","unstructured":"Sepich-Poore GD, Zitvogel L, Straussman R, Hasty J, Wargo JA, Knight R. The microbiome and human cancer. Science. 2021;371(6536):eabc4552. https:\/\/doi.org\/10.1126\/science.abc4552.","journal-title":"Science"},{"issue":"8","key":"3883_CR105","doi-asserted-by":"publisher","first-page":"e2105716","DOI":"10.1002\/smll.202105716","volume":"18","author":"Y Yao","year":"2022","unstructured":"Yao Y, Li J, Li P, et al. Bacterially synthesized tellurium nanorods for elimination of advanced malignant tumor by photothermal immunotherapy. Small. 2022;18(8):e2105716. https:\/\/doi.org\/10.1002\/smll.202105716.","journal-title":"Small"},{"issue":"33","key":"3883_CR106","doi-asserted-by":"publisher","first-page":"e2504769","DOI":"10.1002\/smll.202504769","volume":"21","author":"J Zuo","year":"2025","unstructured":"Zuo J, Ma Z, Su Z, et al. A photothermal agent with multiple hot shock proteins inhibition for enhanced tumor photothermal therapy and intrinsic apoptosis. Small. 2025;21(33):e2504769. https:\/\/doi.org\/10.1002\/smll.202504769.","journal-title":"Small"}],"container-title":["Journal of Nanobiotechnology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1186\/s12951-025-03883-0.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/article\/10.1186\/s12951-025-03883-0","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1186\/s12951-025-03883-0.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2026,1,5]],"date-time":"2026-01-05T15:48:52Z","timestamp":1767628132000},"score":1,"resource":{"primary":{"URL":"https:\/\/link.springer.com\/10.1186\/s12951-025-03883-0"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2025,11,29]]},"references-count":106,"journal-issue":{"issue":"1","published-online":{"date-parts":[[2026,12]]}},"alternative-id":["3883"],"URL":"https:\/\/doi.org\/10.1186\/s12951-025-03883-0","relation":{},"ISSN":["1477-3155"],"issn-type":[{"value":"1477-3155","type":"electronic"}],"subject":[],"published":{"date-parts":[[2025,11,29]]},"assertion":[{"value":"5 March 2025","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"19 November 2025","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"29 November 2025","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Declarations"}},{"value":"Not applicable.","order":2,"name":"Ethics","group":{"name":"EthicsHeading","label":"Ethics approval and consent to participate"}},{"value":"Not applicable.","order":3,"name":"Ethics","group":{"name":"EthicsHeading","label":"Consent for publication"}},{"value":"The authors declare no competing interests.","order":4,"name":"Ethics","group":{"name":"EthicsHeading","label":"Competing interests"}}],"article-number":"7"}}